StARR Scholars
Isabel Hardee, MD
Dr. Isabel Hardee is a pediatric resident at University of Colorado, interested in pursuing a career in pediatric emergency medicine with a focus on precision medicine and translational research. Dr. Hardee earned her BS in Chemistry from the College of William & Mary, and her MD from Emory University’s School of Medicine. She has also worked at the NIH, studying the genetic basis of rare diseases as a through the Undiagnosed Diseases Program.
Dr. Hardee’s StARR research project aims to characterize pediatric patients presenting to the emergency department with undifferentiated wheeze using transcriptome modeling. Longitudinally, she hopes to build towards a personalized care model of treatment prior to the age at which these children are given a formal diagnosis of asthma. She will be working under the primary mentorship of Rakesh Mistry, MD, with additional mentorship by Andy Liu, MD, in collaboration with Max Seibold, PhD, at National Jewish Health.
August Logino, MD
Natalie Longino, MD
Dr. Natalie Longino is a second year resident in the University of Colorado internal medicine Physician Scientist Training Program (PSTP) with plans to specialize in hematology and oncology. Natalie completed her MD and PhD at the University of Washington where she studied the immunobiology of Merkel cell carcinoma. Her ongoing research interests including comparing and contrasting the immunobiology of pregnancy and cancer. During her year in the StARR program, she will study a unique cell type called decidual Natural Killer cells to determine whether melanoma tumors are employing this unique cell type to create an immune tolerant environment similar to the immune microenvironment found in the pregnant uterus.
Past StARR Scholar
Jayce Pangilinan, MD
Dr. Jayce Pangilinan was selected as the first scholar of the University of Colorado Departments of Medicine and Pediatrics Stimulating Access to Research in Residency (StARR) program, which began July 1, 2020.
Dr. Pangilinan recently completed her internal medicine internship at the University of Colorado and plans to pursue a fellowship in pulmonary and critical care medicine. Ultimately, she would like to pursue a career in academic medicine with a focus on translational research in mechanisms underlying critical illness. Dr. Pangilinan received her BA in human biology from Stanford University, and graduated from medical school at the University of Arizona.
For her StARR project, Dr. Pangilinan plans to characterize the inflammatory response in acute respiratory distress syndrome (ARDS) within the air spaces of critically ill patients with COVID-19. To achieve this, she will analyze immune cell populations and inflammatory markers in bronchoalveolar lavage (BAL) fluid and serum of patients with COVID-19 ARDS during their clinical course. She will be working under the primary mentorship of Kara Mould, MD, in the laboratory and under the broader mentorship of William Janssen, MD, at National Jewish Health.